AG00GTX5

859212-16-1 | Bafetinib

Chemical structure of Bafetinib, CAS 859212-16-1
AG00GTX5
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 859212-16-1
Catalog Number AG00GTX5(AGN-PC-0V2HN7)
Chemical Name Bafetinib
IUPAC Name 4-[[(3S)-3-(dimethylamino)pyrrolidin-1-yl]methyl]-N-[4-methyl-3-[(4-pyrimidin-5-ylpyrimidin-2-yl)amino]phenyl]-3-(trifluoromethyl)benzamide
InChI InChI=1S/C30H31F3N8O/c1-19-4-7-23(13-27(19)39-29-36-10-8-26(38-29)22-14-34-18-35-15-22)37-28(42)20-5-6-21(25(12-20)30(31,32)33)16-41-11-9-24(17-41)40(2)3/h4-8,10,12-15,18,24H,9,11,16-17H2,1-3H3,(H,37,42)(H,36,38,39)/t24-/m0/s1
InChI Key ZGBAJMQHJDFTQJ-DEOSSOPVSA-N
MDL Number MFCD18633200
Molecular Formula C30H31F3N8O
Molecular Weight 576.6153
SMILES N1=C(N=C(C=C1)C=1C=NC=NC1)NC=1C=C(C=CC1C)NC(C1=CC(=C(C=C1)CN1C[C@H](CC1)N(C)C)C(F)(F)F)=O
UNII NVW4Z03I9B
Synonyms
bafetinib, INNO-406, NS-187, Bafetinib, 859212-16-1, INNO-406, NS-187, UNII-NVW4Z03I9B, INNO 406, CNS-9, NVW4Z03I9B, INNO406, CHEMBL206834, (S)-N-(3-([4,5'-bipyrimidin]-2-ylamino)-4-methylphenyl)-4-((3-(dimethylamino)pyrrolidin-1-yl)methyl)-3-(trifluoromethyl)benzamide, 4-[[(3S)-3-DIMETHYLAMINOPYRROLIDIN-1-YL]METHYL]-N-[4-METHYL-3-[(4-PYRIMIDIN-5-YLPYRIMIDIN-2-YL)AMINO]PHENYL]-3-(TRIFLUOROMETHYL)BENZAMIDE, NS 187, (S)-N-(3-(4,5'-bipyrimidin-2-ylamino)-4-methylphenyl)-4-((3-(dimethylamino)pyrrolidin-1-yl)methyl)-3-(trifluoromethyl)benzamide, n-(3-((4,5'-bipyrimidin)-2-ylamino)-4-methylphenyl)-4-(((3s)-3-(dimethylamino)-1-pyrrolidinyl)methyl)-3-(trifluoromethyl)benzamide, N-[3-(4,5'-Bipyrimidin-2-Ylamino)-4-Methylphenyl]-4-{[(3s)-3-(Dimethylamino)pyrrolidin-1-Yl]methyl}-3-(Trifluoromethyl)benzamide, Bafetinib [USAN:INN], Bafetinib (USAN), Bafetinib - INNO-406, GTPL7906, QCR-84, SCHEMBL2684766, SYN1179, BCP22045, EX-A1534, BDBM50178612, s1369, ZINC22940637, AN-3554, CS-5142, DB11851, RL05315, SB16616, NCGC00386698-03, AS-16314, BC252523, HY-50868, FT-0662470, A10119, D10202, 212D161, J-522973, (S)-4-((3-(dimethylamino)pyrrolidin-1-yl)methyl)-N-(4-methyl-3-(4-(pyrimidin-5-yl)pyrimidin-2-ylamino)phenyl)-3-(trifluoromethyl)benzamide, 4-((3-(dimethylamino)pyrrolidin-1-yl)methyl)-N-(4-methyl-3-(4-(pyrimidin-5-yl)pyrimidin-2-ylamino)phenyl)-3-(trifluoromethyl)benzamide, Benzamide, N-(3-((4,5'-bipyrimidin)-2-ylamino)-4-methylphenyl)-4-(((3S)-3-(dimethylamino)-1-pyrrolidinyl)methyl)-3-(trifluoromethyl)-, N-[3-([4,5'-bipyrimidin]-2-ylamino)-4-METhylphenyl]-4-[[(3S)-3-(dimethylamino)-1- pyrrolidinyl] methyl]-3-(trifluoromethyl)-benzamide, N-[3-(4,5''-BIPYRIMIDIN-2-YLAMINO)-4-METHYLPHENYL]-4-{[(3S)-3-(DIMETHYLAMINO)PYRROLIDIN-1-YL]METHYL}-3-(TRIFLUOROMETHYL)BENZAMIDE, Bafetinib [INN], Bafetinib (INNO-406), Lyn-IN-1, D0G0VV, C30H31F3N8O, CID11387605, CID 11387605, 4-[[(3S)-3-(dimethylamino)pyrrolidin-1-yl]methyl]-N-[4-methyl-3-[(4-pyrimidin-5-ylpyrimidin-2-yl)amino]phenyl]-3-(trifluoromethyl)benzamide,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited